• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏膜和肺肝素的抗凝效力

Anticoagulant potency of mucosal and lung heparin.

作者信息

McMahon F G, Jain A K, Ryan J R, Lefton T E

出版信息

Clin Pharmacol Ther. 1975 Jan;17(1):79-82. doi: 10.1002/cpt197517179.

DOI:10.1002/cpt197517179
PMID:1168110
Abstract

Hog mucosal heparin was compared with beef lung heparin in 24 healthy male and female subjects by double-blind crossover study, by both intravenous and subcutaneous routes, to determine their relative anticoagulant effects as estimated by the activated partial thromboplastin test. Both drugs by both routes induced therapeutically comparable anticoagulation effects, without adverse experience. Thus both products are equivalent, unit for unit.

摘要

通过双盲交叉研究,在24名健康男性和女性受试者中,经静脉和皮下途径,比较了猪黏膜肝素和牛肺肝素,以活化部分凝血活酶试验评估它们的相对抗凝效果。两种药物经两种途径均诱导出治疗上相当的抗凝效果,且无不良事件。因此,两种产品在单位剂量上是等效的。

相似文献

1
Anticoagulant potency of mucosal and lung heparin.黏膜和肺肝素的抗凝效力
Clin Pharmacol Ther. 1975 Jan;17(1):79-82. doi: 10.1002/cpt197517179.
2
Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.监测接受普通肝素治疗的静脉血栓栓塞症患者的活化部分凝血活酶时间与临床结局的关系。
Thromb Haemost. 2009 Nov;102(5):879-86. doi: 10.1160/TH09-06-0404.
3
Pharmacodynamics of the anticoagulant activity (APTT) of an algal polysaccharide.一种藻类多糖抗凝活性(活化部分凝血活酶时间)的药效学
Thromb Res. 2002 Mar 1;105(5):455-7. doi: 10.1016/s0049-3848(02)00047-6.
4
Anticoagulant activity of two commercially available heparin preparations. A controlled study.两种市售肝素制剂的抗凝活性。一项对照研究。
J Clin Pharmacol New Drugs. 1972 Oct;12(10):413-6. doi: 10.1002/j.1552-4604.1972.tb00142.x.
5
Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy.妊娠晚期早期皮下注射肝素的药代动力学和药效学
Am J Obstet Gynecol. 1995 Oct;173(4):1240-5. doi: 10.1016/0002-9378(95)91362-9.
6
[Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa].[从猪肠黏膜中分离得到的肝素钠盐和钙盐抗凝活性的比较评估]
Farmakol Toksikol. 1989 May-Jun;52(3):51-5.
7
Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs.一种新型强效肝素的特性。第六篇通讯:新型强效肝素钠盐和钙盐在比格犬皮下注射后的抗凝效果比较。
Arzneimittelforschung. 1981;31(1):79-82.
8
Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration.静脉注射和皮下注射肝素引起的血栓弹力图改变。
Semin Thromb Hemost. 1995;21 Suppl 4:53-8. doi: 10.1055/s-0032-1313622.
9
Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.特发性肺纤维化患者吸入肝素的安全性和耐受性。
J Aerosol Med Pulm Drug Deliv. 2010 Jun;23(3):161-72. doi: 10.1089/jamp.2009.0780.
10
Modest doses of nitroglycerin do not interfere with beef lung heparin anticoagulation in patients taking nitrates.小剂量硝酸甘油不会干扰正在服用硝酸盐类药物患者的牛肺肝素抗凝作用。
J Cardiothorac Vasc Anesth. 1992 Dec;6(6):677-9. doi: 10.1016/1053-0770(92)90050-h.

引用本文的文献

1
Clinical pharmacokinetics of heparin.肝素的临床药代动力学
Clin Pharmacokinet. 1980 May-Jun;5(3):204-20. doi: 10.2165/00003088-198005030-00002.